19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
(+/-) 3-Amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole: a conformationally restricted analogue of 5-carboxamidotryptamine with selectivity for the serotonin 5-HT1D receptor.
SmithKline Beecham Pharmaceuticals Ltd
Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic?
UCB Pharma SA
First tricyclic oximino derivatives as 5-HT3 ligands.
Universit£ de Caen
Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists.
Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Virginia Commonwealth University
(Dipropylamino)-tetrahydronaphthofurans: centrally acting serotonin agonists and dopamine agonists-antagonists
agonist activity of a series of meso
The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053)
5-O-Carboxymethyl piperazide derivatives of serotonin: a new class of potent and selective 5-HT1D
The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4
)/platelet activating factor (PAF) receptor antagonists.
Novel conformationally restricted aromatic piperidines as selective sigma receptor ligands
Novel ether derivatives of alkyl piperidines as potential sigma / 5HT2
Bridgehead-methyl analog of SC-53116 as a 5-HT4 agonist.
1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.
Novel phenylpiperazine derivatives as dual cytokine regulators with TNF-alpha suppressing and IL-10 augmenting activity.
Yoshitomi Pharmaceutical Industries Ltd
Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.
Harvard Medical School
Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor.